Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.

Abstract excerpt

BACKGROUND: While cure rates for childhood acute lymphoblastic leukemia (cALL) now exceed 80%, over 60% of survivors will face treatment-related long-term sequelae, including cardiometabolic complications such as obesity, insulin resistance, dyslipidemia and hypertension. Although genetic susceptibility contributes to the development of these problems, there are very few studies that have so far addressed this...

Topics

Join the communities discussing this publication.

• bcl-Associated Death Protein
• Cancer Survivors
• Exome Sequencing
• Hypertension
• Insulin Resistance